InvestorsHub Logo
Followers 5
Posts 368
Boards Moderated 0
Alias Born 10/24/2019

Re: None

Monday, 06/14/2021 8:25:20 AM

Monday, June 14, 2021 8:25:20 AM

Post# of 2072
$AIM is headed up in the premarket hours after a peer-reviewed publication shows Ampligen has potential as a COVID-19 treatment in cancer patients. https://cnafinance.com/aim-immunotech-aim-stock-climbs-on-ampligen-publication/
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AIM News